SEDANA — Sedana Medical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK946.68m
- SEK913.23m
- SEK200.23m
Brief: Sedana Medical Sees Increased Demand As A Result Of COVID-19 Pandemic
Brief: Sedana Medical Q4 EBIT Loss Widens To SEK 5.0 Million
Brief: Sedana Medical Establishes Sales Organization In Benelux
Brief: Sedana Medical Receives Approval For AnaConDa In Mexico
Brief: Sedana Medical Says CEO Divests Shares
Brief: Sedana Medical Funds A Large Study With Isoflurane
Brief: Sedana Medical Q3 EBIT Loss Widens To SEK 5.1 Mln
Brief: Sedana Medical Says Board Member Michael Ryan Resigns
Brief: Sedana Medical Adjusts, Clarifies Long-Term Financial Targets
Brief: Sedana Medical Raises SEK 375 Mln In Directed Share Issue
Brief: Sedana Medical Prepares For Listing On The Nasdaq Stockholm Main Market
Brief: Sedana Medical AB Intends To Undertake A Directed New Share Issue
Brief: Sedana Medical: AnaConDa Approved For Use In Children
Brief: Sedana Medical Q2 EBITDA Loss Widens To Sek 2.3 Million
Brief: Sedana Medical Q2 EBITDA Loss Widens To SEK 2.33 Mln
Brief: Sedana Medical Signs Agreement With Indian Distributor
Brief: Sedana Medical Signs Distribution Deal With Chinese Distributor
Brief: Sedana Medical Q1 EBITDA Loss Widens To SEK 2.6 Million
Brief: Sedana Medical: FDA Positive About Combination Registration Of Isoconda And Anaconda In US